Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ABI H3733

Next Previous
Search
Drug Profile

ABI H3733

Alternative Names: 3733; ABI-H03733; ABI-H3733

Latest Information Update: 17 Aug 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Indiana University
  • Developer Assembly Biosciences
  • Class Antivirals; Small molecules
  • Mechanism of Action Viral core protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Suspended Hepatitis B

Most Recent Events

  • 21 Jun 2023 Pharmacokinetic data from a phase Ia/Ib pharmacokinetic trial in Hepatitis B presented at the European Association for the Study of the Liver Congress 2023 (EASL-2023)
  • 21 Jun 2023 Pharmacokinetic, efficacy and adverse events data from a phase I trial in Hepatitis B presented at the European Association for the Study of the Liver Congress 2023 (EASL-2023)
  • 21 Jun 2023 Efficacy and adverse event data from a phase I trial in Hepatitis B released by Assembly Biosciences

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top